Drug Trial Radar · NCT04102371
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
Last checked: Nov 19, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
9,041
Actual
Start
Aug 25, 2020
Primary completion
Dec 1, 2025
Study completion Jan 31, 2026
Sponsor
- Lead sponsor
- Children's Hospital of PhiladelphiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Boston Children's Hospital; Children's Healthcare of Atlanta; Children's Hospital Colorado; Children's Hospital Los Angeles; University of Pittsburgh; Children's Hospital and Health System Foundation, Wisconsin; Children's Medical Center Dallas; Children's National Research Institute; Children's Hospital Medical Center, Cincinnati; Hasbro Children's Hospital; Ann & Robert H Lurie Children's Hospital of Chicago; Nationwide Children's Hospital; Primary Children's Hospital; Seattle Children's Hospital; St. Louis Children's Hospital; Baylor College of Medicine; University of California, Davis; University of California, San Francisco; University of Michigan; Kidz First Hospital Middlemore; Gold Coast Hospital and Health Service; Queensland Children's Hospital; Westmead Children's Hospital; Sydney Children's Hospitals Network; Perth Children's Hospital; Starship Children's Hospital; Monash Children's Hospital; Women's and Children's Hospital, Australia; Royal Children's Hospital; Royal Darwin Hospital; Virginia Commonwealth University; Alberta Children's Hospital; British Columbia Children's Hospital; Centre Hospitalier Univeritaire Sainte Justine; Centre Hospitalier Universitaire de Quebec; Children's Hospital of Eastern Ontario; The Hospital for Sick Children; IWK Health Centre; Jim Pattison Children's Hospital; Kingston Health Sciences Centre; London Health Sciences Centre; McMaster Children's Hospital; Stollery Children's Hospital; The Children's Hospital of Winnipeg; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Pennsylvania Department of Health; Townsville University Hospital; Hospital nacional de niños Costa Rica; Morgan Stanley Children's Hospital
- First posted
- Sep 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 months, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectives of this multicenter pragmatic clinical trial are to compare the effectiveness and relative safety of balanced fluid resuscitation versus 0.9% "normal" saline in children with septic shock, including whether balanced fluid resuscitation can reduce progression of kidney injury.
Conditions
- Shock
- Septic
Interventions
Lactated RingerDrug
LR is a sterile, nonpyrogenic "balanced" solution used for fluid and electrolyte replenishment via intravenous or intraosseous administration. Each 100 mL of LR contains 600 mg sodium chloride (NaCl), 310 mg of sodium lactate (C3H5NaO3), 30 mg of potassium chloride (KCl), and 20 mg of calcium chloride (CaCl2 · 2H20) with an approximate potential of hydrogen (pH) of 6.5 (6.0 to 7.5).
Normal SalineDrug
Normal saline solution is an "unbalanced" crystalloid solution containing 154 mEq/L of sodium and 154 milliequivalent (mEq/L) of chloride.
Plasma-lyteDrug
PL is a sterile, nonpyrogenic isotonic solution in a single dose container for intravenous administration. Each 100 mL contains 526 mg of Sodium Chloride, USP (NaCl); 502 mg of Sodium Gluconate (C6H11NaO7); 368 mg of Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O); 37 mg of Potassium Chloride, USP (KCl); and 30 mg of Magnesium Chloride, USP (MgCl2•6H2O). It contains no antimicrobial agents. The pH is adjusted with sodium hydroxide. The pH is 7.4 (6.5 to 8.0).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with Major Adverse Kidney Events within 30 days (MAKE30)Time frame: Between randomization and 30 days post enrollment, discharge or death, whichever comes first.
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
UC Davis: University of California, Davis
Davis, California
CHLA: Children's Hospital Los Angeles
Los Angeles, California
UCSF Benioff Children's Hospital
San Francisco, California
Children's Colorado: University of Colorado
Denver, Colorado
Children's Hospital of Atlanta
Emory, Georgia
Lurie Children's: Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Boston Children's Hospital
Boston, Massachusetts
CS Mott Children's Hospital
Ann Arbor, Michigan
Washington University
St Louis, Missouri
Columbia: New York-Presbyterian Hospital
New York, New York
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Nationwide Children's Hospital
Columbus, Ohio
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
Hasbro Children's Hospital
Providence, Rhode Island
Dallas Children's: Children's Medical Center Dallas/UT southwestern
Dallas, Texas
Texas Children's Hospital
Houston, Texas
Primary Children's: University of Utah
Salt Lake City, Utah
Children's Hospital of Richmond at VCU
Richmond, Virginia
Children's National Medical Center
Columbia, Washington
Seattle Children's Hospital
Seattle, Washington
Milwaukee (MCW): Medical College of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.